Crowdsourcing for clinical trials and to enhance medical diagnosis
Medical crowdsourcing enables effective collaboration on everything from diagnosis to clinical trials.
Medical crowdsourcing enables effective collaboration on everything from diagnosis to clinical trials.
The increased patient-centric focus in drug development by the FDA is highly encouraging and expected to become more mainstream and legislated.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Despite the relative paucity of peer-reviewed studies for IVDs in general, several companies are taking steps to publish their data, which can ultimately lead to positive coverage decisions by payers
In vitro diagnostics, particularly lab-developed tests, designed for precision medicine may be among those impacted the most by risk-based frameworks, both overseas and in the U.S.
In virtually every other industry, the use of data analytics has been revolutionary, allowing companies to optimize their product and procedures.
A look at the advantages of different engineering models that in vitro diagnostic companies should consider adopting to improve production.
Because in vitro diagnostics are so integral to patient care, particularly for oncology, developers must be aware of how quality and efficacy data pertaining to their device will be used.
Which in vitro diagnostics are filling providers’ needs? Are they deficient in a performance characteristic that your IVD will improve upon or have you developed a new method that is more cost-efficient?
Global demand for home healthcare services will exceed a market value of $391 billion by 2021. Diagnostics equipment, including IVDs, account for more than one-third of the overall home healthcare equipment market and that share is expected to grow.
Realistic expectations are essential when forecasting both the adoption of the device and the length of time needed for payers to reimburse for the test to ensure adequate working capital, writes Harry Glorikian.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.